Chemoinformaics analysis of 2,5-DIHYDROXYBENZOIC-ACID
| Molecular Weight | 154.121 | nRot | 1 |
| Heavy Atom Molecular Weight | 148.073 | nRig | 7 |
| Exact Molecular Weight | 154.027 | nRing | 1 |
| Solubility: LogS | -1.635 | nHRing | 0 |
| Solubility: LogP | 1.636 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 18.8988 |
| nHD | 3 | BPOL | 6.88724 |
| QED | 0.522 |
| Synth | 1.804 |
| Natural Product Likeliness | 0.739 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.004 |
| HIA | 0.017 |
| CACO-2 | -5.418 |
| MDCK | 0.00000536 |
| BBB | 0.164 |
| PPB | 0.522507 |
| VDSS | 0.36 |
| FU | 0.427778 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.083 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.046 |
| CYP2c9-inh | 0.149 |
| CYP2c9-sub | 0.215 |
| CYP2d6-inh | 0.023 |
| CYP2d6-sub | 0.144 |
| CYP3a4-inh | 0.053 |
| CYP3a4-sub | 0.042 |
| CL | 11.533 |
| T12 | 0.941 |
| hERG | 0.031 |
| Ames | 0.015 |
| ROA | 0.234 |
| SkinSen | 0.331 |
| Carcinogencity | 0.046 |
| EI | 0.968 |
| Respiratory | 0.699 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.793835 |